<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04065451</url>
  </required_header>
  <id_info>
    <org_study_id>1908473351</org_study_id>
    <nct_id>NCT04065451</nct_id>
  </id_info>
  <brief_title>Effect of Epinephrine on Post-polypectomy Pain</brief_title>
  <official_title>Effect of Epinephrine on Immediate Post-polypectomy Pain in Rectal Lesions Larger Than 20 mm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epinephrine is widely used in endoscopic mucosal resection of large polyps to prevent
      post-polypectomy bleeding. No previous studies looked at increase in immediate
      post-polypectomy pain with the use of epinephrine.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Anticipated">December 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immediate post-polypectomy pain</measure>
    <time_frame>30 minutes after the procedure</time_frame>
    <description>Pain related by the participant on a 0-100 visual analog scale; patients will be asked to mark their pain level on a straight vertical line 100 mm long and this point will be measured with a ruler for pain score. Possible values are zero- indicating no pain at all to 100-indicating worst imaginable pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>en bloc resection</measure>
    <time_frame>During the colonoscopy procedure</time_frame>
    <description>yes or no for complete removal of the polyp en bloc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sydney resection quotient</measure>
    <time_frame>During the colonoscopy procedure</time_frame>
    <description>size of the polyp in mm divided by the number of pieces the polyps is removed in</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of the mound</measure>
    <time_frame>During the colonoscopy procedure</time_frame>
    <description>endoscopist impression of lift provided by the submucosal injection, excellent, good or inadequate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Colonic Polyp</condition>
  <arm_group>
    <arm_group_label>Epinephrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epinephrine in the submucosal injection fluid (1:200,000)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No epinephrine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Submucosal injection fluid without epinephrine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <description>Epinephrine in the submucosal injection fluid</description>
    <arm_group_label>Epinephrine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Patients aged 18 years and over

          2. Patients scheduled for treatment of large (â‰¥ 20 mm) rectal polyps

          3. Able to sign informed consent

        Exclusion Criteria

          1. Patients previously enrolled in the study

          2. Pedunculated polyps

          3. Polyps not amenable to endoscopic resection

          4. Patients allergic or sensitive to epinephrine

          5. Patients with coronary artery disease who have had a myocardial infarction in the past
             year, or had coronary stenting in the past year, or had angina in the past year.

          6. Patients electing anesthesia other than monitored anesthesia care with propofol (MAC)
             for colonoscopy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas K Rex, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Krishna Vemulapalli, MBBS</last_name>
    <phone>3179480117</phone>
    <email>kvemulap@iu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Indiana University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas Rex, MD</last_name>
      <phone>317-948-8741</phone>
    </contact>
    <contact_backup>
      <last_name>Krishna Vemulapalli, MBBS</last_name>
      <phone>3179482031</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 15, 2019</study_first_submitted>
  <study_first_submitted_qc>August 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2019</study_first_posted>
  <last_update_submitted>January 17, 2020</last_update_submitted>
  <last_update_submitted_qc>January 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Douglas K. Rex</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

